BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27230279)

  • 21. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
    Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
    Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
    Wong CC; Wong CM; Tung EK; Au SL; Lee JM; Poon RT; Man K; Ng IO
    Gastroenterology; 2011 Jan; 140(1):322-31. PubMed ID: 20951699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients.
    Wang Q; Fiel MI; Luan W; Blank S; Kadri H; Kim KW; Hiotis SP
    Ann Surg Oncol; 2013 Nov; 20(12):3761-70. PubMed ID: 23771248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Wang J; Dong L; Xu L; Chu ES; Chen Y; Shen J; Li X; Wong CC; Sung JJ; Yu J
    Cancer Lett; 2014 Dec; 355(2):192-200. PubMed ID: 25218345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.
    Liu S; Guo W; Shi J; Li N; Yu X; Xue J; Fu X; Chu K; Lu C; Zhao J; Xie D; Wu M; Cheng S; Liu S
    J Hepatol; 2012 Feb; 56(2):389-96. PubMed ID: 21888875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
    Li Y; Tian B; Yang J; Zhao L; Wu X; Ye SL; Liu YK; Tang ZY
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):460-8. PubMed ID: 15146329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genistein reinforces the inhibitory effect of Cisplatin on liver cancer recurrence and metastasis after curative hepatectomy.
    Chen P; Hu MD; Deng XF; Li B
    Asian Pac J Cancer Prev; 2013; 14(2):759-64. PubMed ID: 23621233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
    He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
    J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
    Parr C; Jiang WG
    Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    Wang ZS; Guo WD; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    PLoS One; 2015; 10(11):e0142727. PubMed ID: 26588210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.